AI assistant
NEOGENOMICS INC — Director's Dealing 2011
May 2, 2011
32227_dirs_2011-05-02_478883bd-dc19-4d3a-815e-7fe303d8f6b3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NEOGENOMICS INC (NGNM.OB)
CIK: 0001077183
Period of Report: 2011-05-02
Reporting Person: DVONCH JEROME J (Prinicpal Accounting Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $0.37 | 2015-07-27 | Common Stock (17500) | Direct | |
| Stock Option (right to buy) | $1 | 2016-09-14 | Common Stock (35000) | Direct | |
| Stock Option (right to buy) | $1.47 | 2017-02-12 | Common Stock (19167) | Direct | |
| Stock Option (right to buy) | $1.49 | 2017-03-14 | Common Stock (50000) | Direct | |
| Stock Option (right to buy) | $1.04 | 2015-07-01 | Common Stock (74000) | Direct | |
| Stock Option (right to buy) | $0.62 | 2016-02-02 | Common Stock (19500) | Direct |
Footnotes
F1: On July 1, 2008 Mr. Dvonch was granted options to purchase 100,000 shares. These were a combination of monthly time based vesting over forty eight months and performance based options. The first exercisable date was July 1, 2008. To date 26,000 shares have been cancelled, 53,500 shares are vested and 20,500 shares are unvested.
F2: On February 2, 2009 Mr. Dvonch was granted options to purchase 26,000 shares with performance based vesting. The first date options became exercisable was December 31, 2009. To date 13,000 shares are exercisable and 6,500 shares have been cancelled. There are 6,500 unvested and non-exercisable options.